Open AccessLong‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
Author(s) -
Brunetti Oronzo,
Calabrese Angela,
Palermo Loredana,
Solimando Antonio Giovanni,
Argentiero Antonella
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2496
Subject(s) - regorafenib , medicine , colorectal cancer , refractory (planetary science) , chemotherapy , disease , oncology , cancer , surgery , physics , astrobiology
Two phase 3 trials reported a prolonged survival in the third‐line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonged stable disease with regorafenib.